RxSight, Inc. (RXST) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $952.38M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-59.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $944.24M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-67.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $936.63M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $53.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $927.76M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $60.00K.
RxSight, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $41.00K | $952.38M | $-59.00K | $-689.02M | $263.34M | $263.34M | 3 month · $7.46M |
| 2026-03-31 | $0.00 | $41.00K | $944.24M | $-67.00K | $-676.92M | $267.30M | $267.30M | 3 month · $7.95M |
| 2025-12-31 | $0.00 | $41.00K | $936.63M | $53.00K | $-661.04M | $275.68M | $275.68M | 12 month · $31.61M |
| 2025-09-30 | $0.00 | $41.00K | $927.76M | $60.00K | $-651.89M | $275.97M | $275.97M | 3 month · $8.11M |
| 2025-06-30 | $0.00 | $41.00K | $920.16M | $-117.00K | $-642.07M | $278.01M | $278.01M | 3 month · $8.55M |
| 2025-03-31 | $0.00 | $41.00K | $909.54M | $15.00K | $-630.28M | $279.32M | $279.32M | 3 month · $7.14M |
| 2024-12-31 | $0.00 | $40.00K | $903.13M | $166.00K | $-622.10M | $281.24M | $281.24M | 12 month · $24.64M |
| 2024-09-30 | $0.00 | $40.00K | $892.86M | $521.00K | $-616.16M | $277.26M | $277.26M | 3 month · $6.55M |
| 2024-06-30 | $0.00 | $40.00K | $885.10M | $-118.00K | $-609.82M | $275.21M | $275.21M | 3 month · $6.11M |
| 2024-03-31 | $0.00 | $37.00K | $767.68M | $-53.00K | $-603.74M | $163.93M | $163.93M | 3 month · $4.70M |
| 2023-12-31 | $0.00 | $36.00K | $754.97M | $-5.00K | $-594.64M | $160.36M | $160.36M | 12 month · $15.75M |
| 2023-09-30 | $0.00 | $36.00K | $746.97M | $-60.00K | $-585.46M | $161.48M | $161.48M | 3 month · $4.07M |
| 2023-06-30 | $0.00 | $35.00K | $730.27M | $-73.00K | $-573.05M | $157.19M | $157.19M | 3 month · $3.96M |
| 2023-03-31 | $0.00 | $34.00K | $704.23M | $-9.00K | $-559.24M | $145.01M | $145.01M | 3 month · $3.29M |
| 2022-12-31 | $0.00 | $28.00K | $636.00M | $-95.00K | $-546.03M | $89.90M | $89.90M | 12 month · $11.40M |
| 2022-09-30 | $0.00 | $28.00K | $626.49M | $-138.00K | $-530.42M | $95.96M | $95.96M | 3 month · $2.88M |
| 2022-06-30 | $0.00 | $27.00K | $623.75M | $-183.00K | $-513.60M | $109.99M | $109.99M | 3 month · $2.90M |
| 2022-03-31 | $0.00 | $27.00K | $620.11M | $-98.00K | $-496.87M | $123.16M | $123.16M | 3 month · $2.65M |
| 2021-12-31 | $0.00 | $27.00K | $617.51M | $-20.00K | $-479.28M | $138.24M | $138.24M | 12 month · $7.58M |
| 2021-09-30 | $0.00 | $27.00K | $614.42M | $-11.00K | $-463.54M | $150.89M | $150.89M | 3 month · $2.01M |
| 2021-06-30 | (m) | $4.00K | $137.84M | $-3.00K | $-450.87M | $-313.40M | $-313.40M | 3 month · $1.41M |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-301.90M | 3 month · $1.24M |
| 2020-12-31 | $0.00 | $0.00 | $0.00 | $-3.00K | $-430.59M | $-430.59M | $-430.59M | 12 month · $4.18M |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-445.86M | 3 month · $1.24M |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-464.33M | 3 month · $1.08M |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-443.35M | 3 month · $623.00K |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-419.81M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |